Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

ClinicalTrials.gov ID: NCT00002662

Public ClinicalTrials.gov record NCT00002662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 7, 2026, 1:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PHASE III COMPARISON OF TAXOTERE (DOCETAXEL) AND TAXOL (PACLITAXEL) IN PATIENTS WITH ADVANCED BREAST CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.

Study identification

NCT ID
NCT00002662
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aventis Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1994 (Type not available)
Primary completion
Not listed
Completion
Jun 2004 (Actual)
Last update posted
Aug 2, 2013

1994 – 2004

United States locations

U.S. sites
32
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
Montclair Regional Cancer Center Birmingham Alabama 35213 —
Highlands Oncology Group, P.A. - Fayetteville Fayetteville Arkansas 72703 —
Northeast Arkansas Clinic Jonesboro Arkansas 72401-3125 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
California Cancer Care, Inc. Greenbrae California 94904-2007 —
Green Cancer Center at Scripps Clinic La Jolla California 92037 —
Sidney Kimmel Cancer Center San Diego California 92121 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010 —
Norwich Cancer Center Norwich Connecticut 06360 —
George Washington University Medical Center Washington D.C. District of Columbia 20037 —
Baptist Regional Cancer Institute - Jacksonville Jacksonville Florida 32207-8554 —
Georgia Cancer Specialists - DeKalb Decatur Georgia 30033 —
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612 —
James Graham Brown Cancer Center at University of Louisville Louisville Kentucky 40202 —
Maine Center for Cancer Medicine and Blood Disorders - Scarborough Scarborough Maine 04074 —
Tufts - New England Medical Center Boston Massachusetts 02111 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0942 —
Southfield Oncology Institute, Inc. Southfield Michigan 48076-3779 —
Mercy Arch Hematology Oncology, P.C. St Louis Missouri 63141 —
Carolinas Hematology-Oncology Associates Charlotte North Carolina 28203 —
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0501 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Hematology Oncology Consultants Inc Columbus Ohio 43235 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Oncology-Hematology Associates Philadelphia Pennsylvania 19107 —
Roger Williams Medical Center Providence Rhode Island 02908-4735 —
Greenville Hospital System Greenville South Carolina 29605 —
Baptist Regional Cancer Center - Knoxville Knoxville Tennessee 37901 —
Charles A. Sammons Cancer Center Dallas Texas 75246 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78284-7811 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226-3596 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2013 · Synced Oct 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002662 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →